Barclays’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $183M | Sell |
|
|||||
|
2025
Q2 | $254M | Buy |
|
|||||
|
2025
Q1 | $204M | Sell |
|
|||||
|
2024
Q4 | $274M | Sell |
|
|||||
|
2024
Q3 | $434M | Buy |
|
|||||
|
2024
Q2 | $368M | Buy |
|
|||||
|
2024
Q1 | $331M | Buy |
|
|||||
|
2023
Q4 | $262M | Buy |
|
|||||
|
2023
Q3 | $210M | Sell |
|
|||||
|
2023
Q2 | $200M | Buy |
|
|||||
|
2023
Q1 | $145M | Sell |
|
|||||
|
2022
Q4 | $165M | Buy |
|
|||||
|
2022
Q3 | $107M | Buy |
|
|||||
|
2022
Q2 | $71.1M | Sell |
|
|||||
|
2022
Q1 | $112M | Sell |
|
|||||
|
2021
Q4 | $309M | Buy |
|
|||||
|
2021
Q3 | $192M | Buy |
|
|||||
|
2021
Q2 | $99.3M | Buy |
|
|||||
|
2021
Q1 | $74.9M | Sell |
|
|||||
|
2020
Q4 | $83.7M | Buy |
|
|||||
|
2020
Q3 | $80.4M | Sell |
|
|||||
|
2020
Q2 | $104M | Buy |
|
|||||
|
2020
Q1 | $80.7M | Sell |
|
|||||
|
2019
Q4 | $91M | Sell |
|
|||||
|
2019
Q3 | $73.8M | Buy |
|
|||||
|
2019
Q2 | $60M | Buy |
|
|||||
|
2019
Q1 | $50.2M | Buy |
|
|||||
|
2018
Q4 | $44.7M | Sell |
|
|||||
|
2018
Q3 | $64.5M | Buy |
|
|||||
|
2018
Q2 | $45.9M | Sell |
|
|||||
|
2018
Q1 | $69.8M | Buy |
|
|||||
|
2017
Q4 | $60.2M | Sell |
|
|||||
|
2017
Q3 | $85.8M | Buy |
|
|||||
|
2017
Q2 | $36.8M | Buy |
|
|||||
|
2017
Q1 | $26.4M | Sell |
|
|||||
|
2016
Q4 | $36.6M | Buy |
|
|||||
|
2016
Q3 | $24.7M | Sell |
|
|||||
|
2016
Q2 | $28.9M | Sell |
|
|||||
|
2016
Q1 | $35.3M | Sell |
|
|||||
|
2015
Q4 | $68.2M | Sell |
|
|||||
|
2015
Q3 | $64.5M | Buy |
|
|||||
|
2015
Q2 | $46.4M | Sell |
|
|||||
|
2015
Q1 | $74.8M | Buy |
|
|||||
|
2014
Q4 | $43.2M | Buy |
|
|||||
|
2014
Q3 | $29.6M | Sell |
|
|||||
|
2014
Q2 | $29.8M | Sell |
|
|||||
|
2014
Q1 | $39.5M | Buy |
|
|||||
|
2013
Q4 | $35.3M | Sell |
|
|||||
|
2013
Q3 | $43.9M | Buy |
|
|||||
|
2013
Q2 | $25.2M | Buy |
|